Global Glaucoma Pharmaceuticals Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 98

Report ID: 6391

Glaucoma is caused due to rise in the intraocular pressure, if persists may lead to permanent eye damage.This increased pressure damages the optic nerve which transmits message to the brain High pressure is built due to the blockage of the trabecular meshwork which results in the accumulation of aqueous humor. Depending on the size of trabecular meshwork blockage, glaucoma can be categorized as open angle and narrow closure glaucoma. In open angle glaucoma trabecular meshwork blockage is wider than narrow angle glaucoma. This disease results in various symptoms such as redness in eye, nausea, vomiting, narrowing in vision and pain. This disease can be diagnosed by measuring eye pressure through tonometry.
Key growth drivers of the market include rising ageing population, healthcare expenditures, medical coverage and new innovative combination drugs. The market players in medication as well as devices segments are totally different and somewhat very fragmented.

The global Glaucoma Pharmaceuticals market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Glaucoma Pharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glaucoma Pharmaceuticals market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Acadia Pharmaceuticals Inc.
Allergan Inc.
Inotek Pharmaceuticals Corporation
Merck & Co. Inc.
Santen Pharmaceutical Co.Ltd.
Novartis International AG
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Prostaglandins Analogues (PGAs)
Non PGAs

Segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce

Table of Contents

Executive Summary
1 Glaucoma Pharmaceuticals Market Overview
1.1 Product Overview and Scope of Glaucoma Pharmaceuticals
1.2 Glaucoma Pharmaceuticals Segment by Type
1.2.1 Global Glaucoma Pharmaceuticals Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Prostaglandins Analogues (PGAs)
1.2.3 Non PGAs
1.3 Glaucoma Pharmaceuticals Segment by Application
1.3.1 Glaucoma Pharmaceuticals Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Drug Stores
1.3.5 Retail Pharmacies
1.3.6 E-Commerce
1.4 Global Glaucoma Pharmaceuticals Market by Region
1.4.1 Global Glaucoma Pharmaceuticals Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Glaucoma Pharmaceuticals Market Size
1.5.1 Global Glaucoma Pharmaceuticals Revenue (2014-2025)
1.5.2 Global Glaucoma Pharmaceuticals Production (2014-2025)

2 Global Glaucoma Pharmaceuticals Market Competition by Manufacturers
2.1 Global Glaucoma Pharmaceuticals Production Market Share by Manufacturers (2014-2019)
2.2 Global Glaucoma Pharmaceuticals Revenue Share by Manufacturers (2014-2019)
2.3 Global Glaucoma Pharmaceuticals Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Glaucoma Pharmaceuticals Production Sites, Area Served, Product Types
2.5 Glaucoma Pharmaceuticals Market Competitive Situation and Trends
2.5.1 Glaucoma Pharmaceuticals Market Concentration Rate
2.5.2 Glaucoma Pharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Glaucoma Pharmaceuticals Production Market Share by Regions
3.1 Global Glaucoma Pharmaceuticals Production Market Share by Regions
3.2 Global Glaucoma Pharmaceuticals Revenue Market Share by Regions (2014-2019)
3.3 Global Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Glaucoma Pharmaceuticals Production
3.4.1 North America Glaucoma Pharmaceuticals Production Growth Rate (2014-2019)
3.4.2 North America Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Glaucoma Pharmaceuticals Production
3.5.1 Europe Glaucoma Pharmaceuticals Production Growth Rate (2014-2019)
3.5.2 Europe Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Glaucoma Pharmaceuticals Production (2014-2019)
3.6.1 China Glaucoma Pharmaceuticals Production Growth Rate (2014-2019)
3.6.2 China Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Glaucoma Pharmaceuticals Production (2014-2019)
3.7.1 Japan Glaucoma Pharmaceuticals Production Growth Rate (2014-2019)
3.7.2 Japan Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Glaucoma Pharmaceuticals Consumption by Regions
4.1 Global Glaucoma Pharmaceuticals Consumption by Regions
4.2 North America Glaucoma Pharmaceuticals Consumption (2014-2019)
4.3 Europe Glaucoma Pharmaceuticals Consumption (2014-2019)
4.4 China Glaucoma Pharmaceuticals Consumption (2014-2019)
4.5 Japan Glaucoma Pharmaceuticals Consumption (2014-2019)

5 Global Glaucoma Pharmaceuticals Production, Revenue, Price Trend by Type
5.1 Global Glaucoma Pharmaceuticals Production Market Share by Type (2014-2019)
5.2 Global Glaucoma Pharmaceuticals Revenue Market Share by Type (2014-2019)
5.3 Global Glaucoma Pharmaceuticals Price by Type (2014-2019)
5.4 Global Glaucoma Pharmaceuticals Production Growth by Type (2014-2019)

6 Global Glaucoma Pharmaceuticals Market Analysis by Applications
6.1 Global Glaucoma Pharmaceuticals Consumption Market Share by Application (2014-2019)
6.2 Global Glaucoma Pharmaceuticals Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Glaucoma Pharmaceuticals Business
7.1 Acadia Pharmaceuticals Inc.
7.1.1 Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Production Sites and Area Served
7.1.2 Glaucoma Pharmaceuticals Product Introduction, Application and Specification
7.1.3 Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Allergan Inc.
7.2.1 Allergan Inc. Glaucoma Pharmaceuticals Production Sites and Area Served
7.2.2 Glaucoma Pharmaceuticals Product Introduction, Application and Specification
7.2.3 Allergan Inc. Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Inotek Pharmaceuticals Corporation
7.3.1 Inotek Pharmaceuticals Corporation Glaucoma Pharmaceuticals Production Sites and Area Served
7.3.2 Glaucoma Pharmaceuticals Product Introduction, Application and Specification
7.3.3 Inotek Pharmaceuticals Corporation Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Merck & Co. Inc.
7.4.1 Merck & Co. Inc. Glaucoma Pharmaceuticals Production Sites and Area Served
7.4.2 Glaucoma Pharmaceuticals Product Introduction, Application and Specification
7.4.3 Merck & Co. Inc. Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Santen Pharmaceutical Co.Ltd.
7.5.1 Santen Pharmaceutical Co.Ltd. Glaucoma Pharmaceuticals Production Sites and Area Served
7.5.2 Glaucoma Pharmaceuticals Product Introduction, Application and Specification
7.5.3 Santen Pharmaceutical Co.Ltd. Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Novartis International AG
7.6.1 Novartis International AG Glaucoma Pharmaceuticals Production Sites and Area Served
7.6.2 Glaucoma Pharmaceuticals Product Introduction, Application and Specification
7.6.3 Novartis International AG Glaucoma Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served

8 Glaucoma Pharmaceuticals Manufacturing Cost Analysis
8.1 Glaucoma Pharmaceuticals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Glaucoma Pharmaceuticals
8.4 Glaucoma Pharmaceuticals Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Glaucoma Pharmaceuticals Distributors List
9.3 Glaucoma Pharmaceuticals Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Glaucoma Pharmaceuticals Market Forecast
11.1 Global Glaucoma Pharmaceuticals Production, Revenue Forecast
11.1.1 Global Glaucoma Pharmaceuticals Production Growth Rate Forecast (2019-2025)
11.1.2 Global Glaucoma Pharmaceuticals Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Glaucoma Pharmaceuticals Price and Trend Forecast (2019-2025)
11.2 Global Glaucoma Pharmaceuticals Production Forecast by Regions (2019-2025)
11.2.1 North America Glaucoma Pharmaceuticals Production, Revenue Forecast (2019-2025)
11.2.2 Europe Glaucoma Pharmaceuticals Production, Revenue Forecast (2019-2025)
11.2.3 China Glaucoma Pharmaceuticals Production, Revenue Forecast (2019-2025)
11.2.4 Japan Glaucoma Pharmaceuticals Production, Revenue Forecast (2019-2025)
11.3 Global Glaucoma Pharmaceuticals Consumption Forecast by Regions (2019-2025)
11.3.1 North America Glaucoma Pharmaceuticals Consumption Forecast (2019-2025)
11.3.2 Europe Glaucoma Pharmaceuticals Consumption Forecast (2019-2025)
11.3.3 China Glaucoma Pharmaceuticals Consumption Forecast (2019-2025)
11.3.4 Japan Glaucoma Pharmaceuticals Consumption Forecast (2019-2025)
11.4 Global Glaucoma Pharmaceuticals Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Glaucoma Pharmaceuticals Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer